Emflaza
Deflazacort
Paket | Her hap | Ücret | Tasarruflar | Sipariş |
---|---|---|---|---|
120 tablet
Ücretsiz Havapostası Gönderisi
Hot
|
₺ 158.83
|
₺ 19059.01₺ 158.83
|
₺ 3458.66
|
|
90 tablet
Ücretsiz Havapostası Gönderisi
Hot
|
₺ 167.48
|
₺ 15073.58₺ 167.48
|
₺ 1814.67
|
|
60 tablet
Ücretsiz Havapostası Gönderisi
Hot
|
₺ 173.25
|
₺ 10395.04₺ 173.25
|
₺ 863.80
|
|
36 tablet
Ücretsiz Havapostası Gönderisi
Hot
|
₺ 182.86
|
₺ 6582.89₺ 182.86
|
₺ 172.41
|
|
24 tablet
|
₺ 187.65
|
₺ 4503.53₺ 187.65
|
|
Paket | Her hap | Ücret | Tasarruflar | Sipariş |
---|---|---|---|---|
90 tablet
Ücretsiz Havapostası Gönderisi
Hot
|
₺ 192.51
|
₺ 17326.22₺ 192.51
|
₺ 3460.82
|
|
60 tablet
Ücretsiz Havapostası Gönderisi
Hot
|
₺ 207.91
|
₺ 12474.39₺ 207.91
|
₺ 1383.64
|
|
36 tablet
Ücretsiz Havapostası Gönderisi
Hot
|
₺ 221.36
|
₺ 7969.12₺ 221.36
|
₺ 345.69
|
|
24 tablet
Ücretsiz Havapostası Gönderisi
Hot
|
₺ 230.97
|
₺ 5543.21₺ 230.97
|
|
Deflazacort tablets
What is this medicine?
Deflazacort a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.
What should I tell my health care providers before I take this medicine?
They need to know if you have any of these conditions:
- Hypersensitivity to deflazacort;
- Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome, and hyperglycemia;
- Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal;
- Alterations in Cardiovascular/Renal Function: elevated blood pressure and sodium, and for decreased potassium level;
- Gastrointestinal Perforation: GI disorders;
- Behavioral and Mood Disturbances: euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis;
- Effects on Bones: decreases in bone mineral density;
- Serious Skin Rashes;
- Ophthalmic Effects: May include cataracts, infections, and glaucoma;
- Vaccination: Do not administer live or live attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids.
How should I use this medicine?
The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally. Discontinue gradually when administered for more than a few day..
What may interact with this medicine?
- Moderate or strong CYP3A4 inhibitors: Give one third of the recommended dosage;
- Avoid use of moderate or strong CYP3A4 inducers, as they may reduce efficacy.
What side effects may I notice from this medicine?
The most common adverse reactions are Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.